Only when signs indicate that the cancer is becoming dangerous is treatment initiated. While this approach is still being studied, the results so far appear promising: men who participate in active surveillance programs are 14 times more likely to die of a cause unrelated to prostate cancer.
在积极监督措施中，因PSA过高而被诊断需进行活体组织检查的患者将推迟治疗，而替之以通过各种后续测试进行密切监视。这一方法仍在研究中，但目前的结果颇令人鼓舞：参与积极监督措施的男性因与前列腺癌无关原因而死亡的可能性要高14倍。